Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor. 2015

Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

BACKGROUND Due to resistance to all classes of anti-HIV drugs and drug toxicity, there is a need for the discovery and development of new anti-HIV drugs. METHODS HIV-1 inhibitors were identified and biologically characterized for mechanism of action. RESULTS We identified a dibenzocyclooctadiene lignan, termed HDS2 that possessed anti-HIV activity against a wide variety of viral strains with EC50 values in the 1-3 µM range. HDS2 was shown to act as an NNRTI by qPCR and in vitro enzyme assays. CONCLUSIONS This compound provides a new scaffold for further optimization of activity through structure-guided design.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
January 1992, Advances in experimental medicine and biology,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
March 2013, Klinicka mikrobiologie a infekcni lekarstvi,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
January 1996, Advances in experimental medicine and biology,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
January 2019, Journal of Asian natural products research,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
April 2006, Journal of medicinal chemistry,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
August 2023, ACS infectious diseases,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
February 2004, Journal of medicinal chemistry,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
May 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
January 2013, PloS one,
Ying-Shan Han, and Wei-Lie Xiao, and Hongtao Xu, and Victor G Kramer, and Yudong Quan, and Thibault Mesplède, and Maureen Oliveira, and Susan P Colby-Germinario, and Han-Dong Sun, and Mark A Wainberg
November 2022, Molecules (Basel, Switzerland),
Copied contents to your clipboard!